# Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer

> **NCT00976131** · PHASE1 · COMPLETED · sponsor: **Columbia University** · enrollment: 7 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** CoQ10
- **OTHER:** CoQ10 Placebo
- **DRUG:** Doxorubicin
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT00976131
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-09-30
- **Final completion:** 2021-01-20
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2022-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976131, "Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00976131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*